mutation predictions | marginal predictions | summary statistics | genome diff | command line log
|
breseq version 0.33.1 revision 8505477f25b3
mutation predictions | marginal predictions | summary statistics | genome diff | command line log |
| Marginal read alignment evidence | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| seq id | position | ref | new | freq | score (cons/poly) | reads | annotation | genes | product | ||
| * | REL606 | 275,418 | 0 | A | C | 41.9% | 41.2 / 10.1 | 31 | F528V (TTT→GTT) | yagW | predicted receptor |
| * | REL606 | 1,795,650 | 0 | A | C | 40.6% | 110.4 / 24.6 | 64 | V39G (GTG→GGG) | celF | cryptic phospho‑beta‑glucosidase, NAD(P)‑binding |
| * | REL606 | 1,882,526 | 0 | T | G | 35.0% | 96.7 / 13.1 | 60 | I21S (ATT→AGT) | manZ | mannose‑specific enzyme IID component of PTS |
| * | REL606 | 4,141,009 | 0 | G | A | 31.0% | 52.8 / 12.6 | 29 | E28K (GAA→AAA) | yijC | DNA‑binding transcriptional repressor |
| * | REL606 | 2,631,772 | 0 | A | C | 30.2% | 102.3 / 11.1 | 43 | intergenic (‑267/‑141) | rpoE/nadB | RNA polymerase, sigma 24 (sigma E) factor/L‑aspartate oxidase |
| * | REL606 | 154,497 | 0 | T | G | 27.1% | 136.8 / 14.3 | 59 | A191A (GCA→GCC) | yadL | predicted fimbrial‑like adhesin protein |
| * | REL606 | 1,747,903 | 0 | G | T | 26.3% | 247.2 / 76.1 | 99 | A8S (GCA→TCA) | ydiL | hypothetical protein |
| * | REL606 | 1,416,838 | 0 | T | G | 25.0% | 146.6 / 14.0 | 64 | intergenic (+1/‑4) | ECB_01334/ECB_01335 | putative Lysozyme/conserved hypothetical protein |
| Marginal new junction evidence (sorted from low to high skew) | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| seq id | position | reads (cov) | reads (cov) | score | skew | freq | annotation | gene | product | ||
| * | ? | REL606 | = 2114544 | 74 (1.410) | 3 (0.070) | 3/132 | 6.3 | 4.1% | coding (130/1968 nt) | ECB_02001 | hypothetical protein |
| ? | REL606 | = 2115058 | 75 (1.630) | intergenic (‑20/+116) | ECB_02002/ECB_02003 | hypothetical protein/hypothetical protein | |||||
| * | ? | REL606 | = 4459012 | 90 (1.720) | 4 (0.080) | 3/136 | 6.4 | 4.4% | coding (299/1653 nt) | yjgL | hypothetical protein |
| ? | REL606 | = 4459506 | 94 (1.990) | coding (793/1653 nt) | yjgL | hypothetical protein | |||||
| * | ? | REL606 | 3022587 = | 95 (1.820) | 3 (0.060) | 3/136 | 6.4 | 3.8% | coding (98/1140 nt) | ECB_02821 | hypothetical protein |
| ? | REL606 | 3022874 = | 68 (1.440) | intergenic (‑190/+384) | ECB_02821/ECB_02822 | hypothetical protein/bifunctional Ribulose 5‑phosphate reductase/CDP‑ribitol pyrophosphorylase | |||||
| * | ? | REL606 | = 2680757 | 83 (1.590) | 4 (0.080) | 3/138 | 6.4 | 4.6% | coding (283/897 nt) | ECB_02511 | ParB family protein |
| ? | REL606 | = 2681225 | 91 (1.890) | coding (751/897 nt) | ECB_02511 | ParB family protein | |||||
| * | ? | REL606 | = 799331 | 92 (1.760) | 3 (0.060) | 3/140 | 6.5 | 4.0% | intergenic (‑56/+728) | ECB_00739/ybhB | hypothetical protein/predicted kinase inhibitor |
| ? | REL606 | = 799578 | 60 (1.230) | intergenic (‑303/+481) | ECB_00739/ybhB | hypothetical protein/predicted kinase inhibitor | |||||
| * | ? | REL606 | 23979 = | NA (NA) | 3 (0.060) | 3/142 | 6.6 | 3.6% | noncoding (689/768 nt) | IS1 | repeat region |
| ? | REL606 | 24489 = | 86 (1.640) | intergenic (‑85/+212) | ECB_00025/ECB_00026 | conserved hypothetical protein/hypothetical protein | |||||